Literature DB >> 33547204

Association Between DPP-4 Inhibitors and COVID-19-Related Outcomes Among Patients With Type 2 Diabetes.

Yunha Noh1, In-Sun Oh1, Han Eol Jeong1, Kristian B Filion2,3, Oriana Hoi Yun Yu3,4, Ju-Young Shin5,6.   

Abstract

Entities:  

Year:  2021        PMID： 33547204     DOI： 10.2337/dc20-1824

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  17 in total

1.  Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Tiantian Han; Shaodi Ma; Chenyu Sun; Huimei Zhang; Guangbo Qu; Yue Chen; Ce Cheng; Eric L Chen; Mubashir Ayaz Ahmed; Keun Young Kim; Raveena Manem; Mengshi Chen; Zhichun Guo; Hongru Yang; Yue Yan; Qin Zhou
Journal:  Arch Med Res       Date:  2021-08-09       Impact factor: 2.235

Review 2.  COVID-19 and metabolic disease: mechanisms and clinical management.

Authors:  Charlotte Steenblock; Peter E H Schwarz; Barbara Ludwig; Andreas Linkermann; Paul Zimmet; Konstantin Kulebyakin; Vsevolod A Tkachuk; Alexander G Markov; Hendrik Lehnert; Martin Hrabě de Angelis; Hannes Rietzsch; Roman N Rodionov; Kamlesh Khunti; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Richard I G Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; K George M M Alberti; Bruno Geloneze; Juliana C Chan; Jean Claude Mbanya; Henry C Onyegbutulem; Ambady Ramachandran; Abdul Basit; Mohamed Hassanein; Gavin Bewick; Giatgen A Spinas; Felix Beuschlein; Rüdiger Landgraf; Francesco Rubino; Geltrude Mingrone; Stefan R Bornstein
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-04       Impact factor: 32.069

3.  Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients.

Authors:  Ákos Nádasdi; György Sinkovits; Ilona Bobek; Botond Lakatos; Zsolt Förhécz; Zita Z Prohászka; Marienn Réti; Miklós Arató; Gellért Cseh; Tamás Masszi; Béla Merkely; Péter Ferdinandy; István Vályi-Nagy; Zoltán Prohászka; Gábor Firneisz
Journal:  Biomark Med       Date:  2022-02-23       Impact factor: 2.851

Review 4.  ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.

Authors:  Bushra Memon; Essam M Abdelalim
Journal:  Acta Physiol (Oxf)       Date:  2021-10-02       Impact factor: 7.523

5.  Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis.

Authors:  Nam Nhat Nguyen; Dung Si Ho; Hung Song Nguyen; Dang Khanh Ngan Ho; Hung-Yuan Li; Chia-Yuan Lin; Hsiao-Yean Chiu; Yang-Ching Chen
Journal:  Metabolism       Date:  2022-03-31       Impact factor: 13.934

Review 6.  The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence.

Authors:  Tianli Zhang; Xiang Tong; Shijie Zhang; Dongguang Wang; Lian Wang; Qian Wang; Hong Fan
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

7.  Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 - A systematic review and meta-analysis.

Authors:  Ahmad Fariz Malvi Zamzam Zein; Wilson Matthew Raffaello
Journal:  Prim Care Diabetes       Date:  2021-12-13       Impact factor: 2.459

Review 8.  Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529).

Authors:  Akiko Yonekawa; Nobuyuki Shimono
Journal:  Biology (Basel)       Date:  2022-03-04

Review 9.  Managing diabetes in diabetic patients with COVID: where do we start from?

Authors:  Angelo Avogaro; Benedetta Bonora; Gian Paolo Fadini
Journal:  Acta Diabetol       Date:  2021-06-25       Impact factor: 4.280

10.  Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.

Authors:  Anna R Kahkoska; Trine Julie Abrahamsen; G Caleb Alexander; Tellen D Bennett; Christopher G Chute; Melissa A Haendel; Klara R Klein; Hemalkumar Mehta; Joshua D Miller; Richard A Moffitt; Til Stürmer; Kajsa Kvist; John B Buse
Journal:  Diabetes Care       Date:  2021-06-16       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.